SkinGen develops, manufactures and markets novel, disruptive technologies and products in the medical, dermatology and medical aesthetic arena. By utilizing a science-based approach, our products deliver on their promise.
SkinGen International is dedicated to developing a novel, safe, yet highly effective portfolio of products that target common dermatologic conditions.
Advances in regenerative medicine create high value opportunities for products that focus on rosacea, seborrheic dermatitis, acne, pigmentation,
hair/lash/brow growth, and post-procedural wound care.
SkinGen International is an amalgamation of talented, experienced management with offices in Canada, USA, and the United Kingdom.
SkinGen International has a cohesive family of sales, marketing, and distribution partners worldwide that are ‘best-of-class’.
Medical, dermatology and medical aesthetic – PURE SKINGENUITY®